TherapeuticsMD (TXMD) Operating Expenses (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Operating Expenses came in at $1.4 million in Q1 2026, down 13.56% YoY from $1.7 million in Q1 2025, and down 40.82% on a QoQ basis from $2.4 million in Q4 2025.
TherapeuticsMD (TXMD) Operating Expenses (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Operating Expenses data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Operating Expenses fell 13.56% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (down 6.65% YoY) and the FY2025 annual result came in at $7.4 million, down 5.86% from the prior year.
- Operating Expenses retreated to $1.4 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $20.1 million in Q4 2022 to a low of $1.3 million in Q4 2024.
- A 5-year average of $5.5 million and a median of $2.1 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 125.87% — and 2023, when it tumbled 89.5%.
- Tracing TXMD's Operating Expenses over 5 years: stood at $20.1 million in 2022, then plunged by 89.5% to $2.1 million in 2023, then plunged by 37.58% to $1.3 million in 2024, then surged by 85.37% to $2.4 million in 2025, then sank by 40.82% to $1.4 million in 2026.
- The last three Operating Expenses figures came in at $1.4 million (Q1 2026), $2.4 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.67 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 3.02 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 2.11 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 2.91 Mn |
| Mar 31, 2023 | 3.08 Mn |
| Dec 31, 2022 | 20.12 Mn |
| Sep 30, 2022 | 14.52 Mn |
| Jun 30, 2022 | 14.86 Mn |
| Mar 31, 2022 | 17.88 Mn |
| Dec 31, 2021 | -77.80 Mn |
| Sep 30, 2021 | 60.05 Mn |